PAXMEDICA (PXMD) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 47 101 sessions, October 23, 2025 to October 23, 2026
- Largest daily move
- +4900% close of October 30, 2025
- 1-year change
- +600% closing prices, October 23, 2025 to October 23, 2026
- 1-month change
- +40% closing prices, September 21, 2026 to October 23, 2026
Company Description
PAXMEDICA (OTC: PXMD) is classified in the biotechnology industry within the Healthcare sector.
PXMD has gained 600.0% over the past year. The last closing price was $0.0007.
For FY2023, PAXMEDICA reported revenue of $0 with net income of -$18.3M and diluted earnings per share of -$11.00.
This page collects what Stock Titan holds for PXMD, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
PAXMEDICA (PXMD) closed at $0.0007 on October 23, 2026. Over the past 12 months, the price has gained 600.0%.
PXMD Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
PAXMEDICA has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include offering, fda approval. View all PXMD news →
SEC Filings
PAXMEDICA has filed 1 recent SEC filing, including 1 Form 10-Q. The most recent filing was submitted on January 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PXMD SEC filings →
Financial Highlights
operating income reached -$16.1M, and net income was -$18.3M. Diluted earnings per share stood at -$11.00. The company generated -$10.8M in operating cash flow. The current ratio was 3.16, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in PAXMEDICA (PXMD) currently stands at 687 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for PAXMEDICA (PXMD) currently stands at 2.0 days, up 29% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 100%. Across the settlements charted above, it has ranged from 1.0 to 5.5 days.
PXMD Company Profile & Sector Positioning
PAXMEDICA (PXMD) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing PXMD often look at related companies in the same sector, including BIOSTAX CORP (BTAX), ARIDIS PHARMACEUTICAL INC (ARDS), NAVIDEA BIOPHARMS INC (NAVB), VIRPAX PHARMS INC (VRPX), and SYROS PHARMACEUTICALS INC (SYRS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PXMD's relative position within its industry.